One study from February 2025, for instance, suggests that people who take glucagon-like peptide-1 receptor agonist medication like Ozempic to treat diabetes have a lower depression risk than peers taking other types of drugs for this metabolic condition
Semaglutide: First global approval
Medicare is prohibited under current law from covering drugs used for weight loss, but Medicare Part D plans can cover GLP-1s for their other medically-accepted indications, including to treat diabetes, and now to cut cardiovascular risk based on a recent memo from the Centers for Medicare & Medicaid Services (CMS)
Data are provided here for scientific reference only
The ad linked to the website Maementcurves.com, which was still active as of Friday , although the page with the weight-loss products appeared to have been taken down after Guardian Australia contacted the site for comment
Sugar-free gum, saliva substitutes, or medications to stimulate saliva production can help maintain the mouths natural protective mechanisms